Background: This study explores the intricate connections between choroidal vascular index (CVI) and noninvasive ultrasonographic atherosclerosis predictors, shedding light on the potential links between ocular vascular dynamics and systemic cardiovascular health. Methods: We conducted a cross-sectional analysis of 81 participants, assessing CVI, intima-media thickness (IMT), extra -media thickness (EMT), and the PATIMA index. The presence of coronary artery disease (CAD) was also evaluated. Statistical methods included descriptive statistics, t -tests for group comparisons, Spearman correlation analysis, and receiver operating characteristic (ROC) curve analysis. Results: Our findings revealed that patients with CAD had lower CVI values compared to those without CAD, underscoring a potential association between CVI and CAD. Significant negative correlations were observed between CVI and IMT, EMT, PATIMA, and CAD. ROC curve analysis identified optimal CVI cutoff values for hypertension and CAD detection, showcasing its potential as a diagnostic marker. Discussion: Our results align with existing literature on ocular vascular changes, supporting the notion that CVI may be a promising indicator of systemic vascular conditions. The study contributes to the broader understanding of the relationships between ocular and cardiovascular health, providing a foundation for future research and clinical applications. Conclusion: The study suggests that CVI holds clinical relevance as a non-invasive marker for identifying systemic conditions, offering insights into the fields of neurology, physical therapy, and rehabilitation. Addressing its limitations, this research encourages further investigation into the multifaceted connections between CVI and atherosclerosis predictors.
Aim: To examine the relationship between complete blood count metrics and the severity of coronary artery disease (CAD) in patients undergoing coronary angiography. Methods: Patients diagnosed with stable angina pectoris or acute coronary syndrome by coronary angiography between October 2018 and February 2019 were included in the study. Based on their angiography results, patients were divided into two groups: one with severe CAD (n=258) and one with non-severe CAD (n=219). The initial clinical characteristics, along with data from laboratory tests and complete blood counts, were recorded and compared between the two groups. Results: The Wight Blood Cell (WBC) count, Neutrophil (NEU) count, Monocyte/Lymphocyte Ratio (MLR), Neutrophil/Lymphocyte Ratio (NLR), Monocyte/High-Density Lipoprotein Cholesterol Ratio (MHR), systemic immune inflammation index (SII) and systemic inflammation response index (SIRI) were each significantly higher in the group with severe CAD than in the group without severe CAD. The analysis utilized logistic regression, factoring in recognized CAD risk factors such as age, gender, diabetes mellitus (DM), hypertension (HT), hyperlipidemia (HL), and smoking, identified NLR, MHR, MLR, SII, and SIRI as notable and independent indicators of severe CAD. Conclusion: Our study showed that since it was an independent predictor of CAD, SII and SIRI could be utilized as a novel indicator for assessing the severity of CAD.
Aim: To examine the relationship between complete blood count metrics and the severity of coronary artery disease (CAD) in patients undergoing coronary angiography. Methods: Patients diagnosed with stable angina pectoris or acute coronary syndrome by coronary angiography between October 2018 and February 2019 were included in the study. Based on their angiography results, patients were divided into two groups: one with severe CAD (n=258) and one with non-severe CAD (n=219). The initial clinical characteristics, along with data from laboratory tests and complete blood counts, were recorded and compared between the two groups. Results: The Wight Blood Cell (WBC) count, Neutrophil (NEU) count, Monocyte/Lymphocyte Ratio (MLR), Neutrophil/Lymphocyte Ratio (NLR), Monocyte/High-Density Lipoprotein Cholesterol Ratio (MHR), systemic immune inflammation index (SII) and systemic inflammation response index (SIRI) were each significantly higher in the group with severe CAD than in the group without severe CAD. The analysis utilized logistic regression, factoring in recognized CAD risk factors such as age, gender, diabetes mellitus (DM), hypertension (HT), hyperlipidemia (HL), and smoking, identified NLR, MHR, MLR, SII, and SIRI as notable and independent indicators of severe CAD. Conclusion: Our study showed that since it was an independent predictor of CAD, SII and SIRI could be utilized as a novel indicator for assessing the severity of CAD.
The study aimed to compare the development of asymptomatic cardiovascular (CV) organ damage in hypertensive patients with and without Sjogren syndrome (SS), a condition characterized by inflammatory processes that lead to vascular damage. Forty hypertensive patients with SS (aged 18–65) and 40 age- and sex-matched hypertensive patients without this syndrome were included into the study. Carotid intima-media thickness was measured from area of 1 cm length proximal to both carotid bulbs. Left ventricular mass index was determined via echocardiography, and microalbuminuria was calculated from spot urine samples. Hypertensive retinopathy was assessed through fundoscopy. Asymptomatic organ damage was found in 51.2% of all participants: 61% in the Sjogren group and 39% in controls, with a statistically significant difference between groups and sexes (P = .041). Carotid intima-media thickness was higher in the Sjogren group (0.815 mm vs 0.607 mm in controls), and left ventricular mass index was significantly elevated in the Sjogren group (92.54 g/m² vs 83.07 g/m², P = .016). All patients with Sjogren disease had at least stage 1 hypertensive retinopathy, while 14 patients in the control group had not. Microalbuminuria values were higher in the Sjogren group but the difference was not statistically significant (P = .082). Hypertensive patients with SS exhibit more asymptomatic organ damage compared to those without the syndrome. Close monitoring and CV screening with measurement of tools which are reflecting subclinical atherosclerosis are recommended for prevention and early detection of overt CV diseases in this population.
3 March 2026 in Frontiers in Cardiovascular Medicine
Background: Subclinical left ventricular (LV) impairment—characterized by reduced global longitudinal strain (GLS) despite normal left ventricular ejection fraction (LVEF)—is frequently encountered in hypertensive patients. While speckle-tracking echocardiography is the standard method for detecting early myocardial dysfunction, it is not universally available. Artificial intelligence–enhanced electrocardiography (AI-ECG) has emerged as a promising tool capable of uncovering subtle electrical patterns linked to early myocardial impairment. This study investigates the diagnostic capability of AI-ECG for detecting GLS-defined subclinical LV dysfunction. Methods: In this retrospective analysis, 348 hypertensive adults who underwent both ECG and echocardiography within the same clinical visit (2022–2024) were evaluated. Subclinical LV dysfunction was defined as LVEF ≥50% and GLS > −18%.A convolutional neural network–based AI algorithm generated an AI-ECG probability score (range 0–1) representing the likelihood of LV dysfunction. Statistical analyses included correlation testing, regression modeling, and ROC curve evaluation. Results: Subclinical LV dysfunction was identified in 134 participants (38.5%). The AI-ECG probability score differed markedly between the abnormal GLS group and the normal GLS group (0.61 ± 0.20 vs. 0.29 ± 0.18; p < 0.001). GLS values demonstrated a strong negative association with AI-ECG scores (r = –0.63). ROC analysis showed robust diagnostic ability with an AUC of 0.86 (95% CI: 0.82–0.89). In multivariable logistic regression adjusting for LV mass index, E/e′, age, and hypertension duration, the AI-ECG probability score remained independently associated with subclinical LV dysfunction (adjusted OR 1.12 per 0.1 increase, 95% CI 1.07–1.18; p < 0.001). Conclusion: AI-ECG accurately detects GLS-defined subclinical LV dysfunction in hypertensive adults and may serve as an accessible tool for early risk stratification in routine clinical settings.
Aim: Coronary artery disease (CAD) is a common manifestation of cardiovascular disease (CVD). The identification of reliable biomarkers for early CAD detection and risk assessment is crucial for effective prevention and management. This article examines the correlation between the uric acid to HDL cholesterol ratio (UHR) and the total calcium score (TCS) obtained from coronary CT angiography (CCTA) in the assessment of CAD. Methods: The study included 60 patients (34 males and 26 females) without endocrine diseases or relevant medications to ensure a homogeneous population. Blood samples collected after an eight hour overnight fasting were analyzed for laboratory parameters. CCTA was performed using a standardized protocol. The total calcium score was calculated using established methods. Results: The analysis showed a significant positive correlation between UHR and TCS (r=0.479, P=0.0001). Patients with coronary artery plaque had significantly higher UHR values compared to those without it (p = 0.001). Conclusion: These findings suggest that UHR could serve as a promising biomarker for predicting CAD presence and severity, although further research is necessary to validate its clinical utility in CAD diagnosis and management.